Company intelligence / Profile preview

Tasso

Seattle, Washington, United Statestassoinc.com ↗

Ownership: Private
Employees: ~108
Development stage: Commercial

Overview

Tasso’s devices enable virtually painless, at-home or remote blood collection for clinical trials, diagnostics, and patient monitoring. The company’s solutions are validated in over 100 peer-reviewed publications and have received regulatory clearance in both the US and EU. Their technology is used to improve patient engagement, retention, access to decentralized trials, and data quality for population pharmacokinetics studies.

Therapeutic areas: CardiovascularImmunologyInfectious Diseases
Modalities: DeviceDigital health solution (for remote blood collection)
Industry: Consumable Medical Devices

Partnerships

Randox Health (UK/Ireland at-home/in-clinic testing partnership)ARUP Laboratories (US reference laboratory collaboration on compatible testing solutions)

Beyond the preview

Go deeper on Tasso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tasso.

Explore the full profile